S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Comparison of Monounsaturated Fatty Acids and Carbohydrates for Lowering Plasma Cholesterol
TL;DR: A diet rich in monounsaturated fatty acids appears to be at least as effective in lowering plasma cholesterol as a diet low in fat and high in carbohydrate in short-term studies in which liquid diets are used and body weight is kept constant.
Journal ArticleDOI
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels
Ishwarlal Jialal,D. Stein,David S. Balis,Scott M. Grundy,Beverley Adams-Huet,Sridevi Devaraj +5 more
TL;DR: Data support an anti-inflammatory effect of these drugs on levels of high-sensitive CRP in patients with combined hyperlipidemia, and there was no relationship between reductions in hs-CRP and LDL cholesterol.
Journal ArticleDOI
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Sidney C. Smith,Emelia J. Benjamin,Robert O. Bonow,Lynne T. Braun,Mark A. Creager,Barry A. Franklin,Raymond J. Gibbons,Scott M. Grundy,Loren F. Hiratzka,Daniel W. Jones,Donald M. Lloyd-Jones,Margo Minissian,Lori Mosca,Eric D. Peterson,Ralph L. Sacco,John A. Spertus,James H. Stein,Kathryn A. Taubert +17 more
TL;DR: In this article, the authors present the 2006 update of the American Heart Association (AHA)/American College of Cardiology Foundation (ACCF) guidelines on secondary prevention and provide evidence from clinical trials that further supports and broadens the merits of intensive risk-reduction therapies for secondary prevention.
Journal ArticleDOI
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology
Sidney C. Smith,Steven N. Blair,Robert O. Bonow,Lawrence M. Brass,Manuel D. Cerqueira,Kathleen Dracup,Valentin Fuster,Antonio M. Gotto,Scott M. Grundy,Nancy Houston Miller,Alice K. Jacobs,Daniel Jones,Ronald M. Krauss,Lori Mosca,Ira S. Ockene,Richard C. Pasternak,Thomas A. Pearson,Marc A. Pfeffer,Rodman D. Starke,Kathryn A. Taubert +19 more
TL;DR: Since the original publication (in 1995) of the AHA consensus statement on secondary prevention, important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease.
Journal ArticleDOI
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus A Scientific Statement From the American Heart Association and the American Diabetes Association
John B. Buse,Henry N. Ginsberg,George L. Bakris,Nathaniel G. Clark,Fernando Costa,Robert H. Eckel,Vivian Fonseca,Hertzel C. Gerstein,Scott M. Grundy,Richard W. Nesto,Michael Pignone,Jorge Plutzky,Daniel Porte,Rita F. Redberg,Kimberly F. Stitzel,Neil J. Stone +15 more
TL;DR: This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.